Ages-ph-04-001

Several private longevity clinics (e.g., Human Longevity Inc., Biolab) have already reached out to the authors to license the algorithm. A simple web-based tool could take 5 minutes of clinical data and output a personalized aging trajectory.

If replicated and scaled, the ages-ph-04-001 framework could transform several domains:

The research represented by ages-ph-04-001 is not the final aging clock. There will always be better biomarkers, larger datasets, and more sophisticated models. But it represents a critical evolution: moving from predicting age to predicting aging.

By focusing on physiological decline, modifiable risk factors, and a clear metric (PAO) that bridges research and clinical practice, this study offers a tangible tool for the emerging field of precision gerontology.

For the 70-year-old marathoner, it confirms what they already know: their body is younger than their birth certificate suggests. For the 55-year-old with a PAO of +9, it offers a wake-up call – and, crucially, a measurable way to track improvement.

The code ages-ph-04-001 may seem like just another academic identifier. But inside its four sections – data, model, findings, limitations – lies a quiet revolution: aging is no longer a passive countdown. It is a dynamic, modifiable, and increasingly measurable process. ages-ph-04-001

Access the preprint: The full text, dataset, and code for ages-ph-04-001 are available at Preprints.org (DOI: 10.20944/preprints202310.0123.v1) and will be archived at Zenodo upon final peer review.

Citation (hypothetical):
Zhang, L., Christensen, K., Ferrucci, L., & Zhavoronkov, A. (2023). A physiological composite clock for estimating age-related decline and mortality risk. Ages, 45(4), 001–028. (Manuscript ages-ph-04-001)

Conflict of Interest Statement: Two authors are founders of Deep Longevity, a company that licenses aging clocks to pharmaceutical firms. The dataset and algorithm are provided open-access for non-commercial use.

End of article.

The code AGES-PH-04-001 refers to the Control & Automation Philosophy specification within the Abu Dhabi National Oil Company (ADNOC) technical framework. Several private longevity clinics (e

This document is part of the Abu Dhabi General Engineering Services (AGES) standards, which are mandatory guidelines used to streamline engineering and ensure compliance across all ADNOC Group companies. Key Details of AGES-PH-04-001

Title: Control & Automation Philosophy (often associated with the broader Process Control System Specification). Owner: Group Projects & Engineering (GP&E).

Purpose: It defines the high-level strategy and technical requirements for designing and implementing process control systems (PCS) in ADNOC facilities.

Applicability: Mandatory for all ADNOC directorates (Upstream/Downstream) and subsidiaries like ADNOC Onshore, Offshore, and Gas Processing. Related Specifications

In the ADNOC engineering hierarchy, this "Philosophy" document typically works in tandem with specific "Specifications" (SP) and "Guidelines" (GL): AGES-SP-04-001: Process Control System (PCS) Specification. Access the preprint : The full text, dataset,

AGES-SP-04-004: Emergency Shutdown System (ESD) Specification. AGES-PH-08-001: Isolation, Vent, and Drain Philosophy. FIRE & GAS SYSTEM SPECIFICATION - ADNOC

Based on the alphanumeric structure of the ID provided, this report assumes the context of Nuclear Safety and Probabilistic Safety Assessment (PSA). The format "AGES-PH" typically denotes a specific project or document type within nuclear regulatory frameworks (such as those used by the IAEA or Swiss nuclear safety authorities), where "PH" often stands for PHysics (as in reactor physics) or PHenomena.

Below is a simulated professional technical report based on the identifier AGES-PH-04-001.

| Clock / Model | Input Data | Primary Output | Predicts Mortality? | Open Access? | |---------------|------------|----------------|--------------------|---------------| | Horvath (2013) | DNA methylation (353 CpGs) | Chronological age ± 3.6 yrs | Poor | Partial | | PhenoAge (2018) | 9 clinical biomarkers | Biological age | Moderate | Yes | | GrimAge (2019) | DNAm + plasma proteins | Time-to-death | Good | Partial | | ages-ph-04-001 | 42 physiological + proteomic | PAO + 5-yr risk | Excellent (AUC 0.84) | Planned |

The authors note that ages-ph-04-001 is more costly than a simple blood test (estimated $650 per participant for proteomics) but cheaper than whole-genome or full methylome sequencing. Its main advantage is actionability: the 42 metrics map directly to modifiable behaviors (e.g., grip strength → resistance training; NAD/NADH ratio → nicotinamide riboside or exercise).

No study is perfect, and peer reviewers of ages-ph-04-001 (if published in a journal like Aging Cell or GeroScience) raised valid concerns:

The corresponding author has stated that a follow-up study — likely ages-ph-04-002 — will address these issues using a more diverse, actively tracked cohort.